Literature DB >> 17436910

Nasal rhinosporidiosis in a mule.

Alexis Berrocal1, Alfonso López.   

Abstract

A mass was removed from the nostril of a mule that exhibited unilateral epistaxis and nasal discharge. Impression smears revealed oval structures consistent with spores of Rhinosporidium seeberi. Microscopically, the mass was composed of fibrovascular granulomatous tissue containing sporangia R. seeberi. Surgical excision and antifungal treatment proved curative.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436910      PMCID: PMC1800950     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  7 in total

1.  Molecular evidence for multiple host-specific strains in the genus Rhinosporidium.

Authors:  Victor Silva; Cristiane N Pereira; Libero Ajello; Leonel Mendoza
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Nasal granuloma caused by Pseudallescheria boydii.

Authors:  J C Brearley; I A McCandlish; M Sullivan; C O Dawson
Journal:  Equine Vet J       Date:  1986-03       Impact factor: 2.888

Review 3.  Rhinosporidiosis: what is the cause?

Authors:  Sarath Nanda Arseculeratne
Journal:  Curr Opin Infect Dis       Date:  2005-04       Impact factor: 4.915

Review 4.  Tropical dermatology: fungal tropical diseases.

Authors:  Omar Lupi; Stephen K Tyring; Michael R McGinnis
Journal:  J Am Acad Dermatol       Date:  2005-12       Impact factor: 11.527

5.  Pathology of equine phycomycosis.

Authors:  A Berrocal; T S van den Ingh
Journal:  Vet Q       Date:  1987-04       Impact factor: 3.320

Review 6.  The class mesomycetozoea: a heterogeneous group of microorganisms at the animal-fungal boundary.

Authors:  Leonel Mendoza; John W Taylor; Libero Ajello
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

7.  Rhinosporidium seeberi: a human pathogen from a novel group of aquatic protistan parasites.

Authors:  D N Fredricks; J A Jolley; P W Lepp; J C Kosek; D A Relman
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.